SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Innova Captab lists with 1.80% premium on the BSE

29 Dec 2023 Evaluate

Innova Captab has debuted at Rs 456.10 on the BSE, up by 8.10 points or 1.80% from its issue price of Rs 448.

The scrip is currently trading at Rs 540.00, up by 92.00 points or 20.54% from its issue price. It has touched a high and low of Rs 541.00 and Rs 452.00 respectively. So far 11.05 lakh shares were traded on the counter.

The offering, which was open for subscription between December 21, 2023 and December 26, 2023 was subscribed 55.26 times. The issue price was fixed at Rs 448 per share i.e. at upper end of price band of Rs 426-448 apiece. 

Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.

Innova Captab Share Price

725.60 -7.65 (-1.04%)
16-Apr-2026 09:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1689.80
Dr. Reddys Lab 1219.00
Cipla 1228.50
Zydus Lifesciences 937.25
Lupin 2313.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×